41 minutes ago
By: Sophie Opp and Anna OlpMarch 22, 2021
By: Emma Schaefer, Design Manager & Production ManagerMarch 22, 2021
By: Sophia Mullins, Co-Editor-in-Chief of Web and Copy EditorMarch 19, 2021
By: Sophie OppFebruary 9, 2021
By: Jenna Lin, Editor-in-Chief of Print
By: Anna Olp, Editor
February 3, 2021
The internet, as many people know, is a hub of information, opinions and powerful numbers of people. A culmination of these combined aspects of the internet can all be found...
January 27, 2021
December 1, 2020
COVID Affecting the Holiday Season
November 20, 2020
When a Coronavirus vaccine becomes available to you, will you take it? This question is resting on the minds of hundreds of millions of Americans, as three strong vaccine candidates have emerged with the FDA’s emergency mark of approval expected very shortly in the United States. The three leading candidates, Pfizer/BioNTech, Moderna and Oxford/AstraZeneca have shown that their vaccines produce strong immune responses in the vast majority of their trial volunteers, with slightly varying degrees of effectiveness. Pfizer and Moderna, both companies based in the U.S., currently have vaccine candidates that have been shown to be nearly 95% effective against COVID-19. While many Americans are cheering on the success of the vaccine trials, others are wary of potential side effects they may encounter. But many infectious disease experts throughout the country are encouraged by the vaccine trial results, and are encouraging people to take them as soon as they become publicly available....
